Inspire Advisors’s Chemed CHE Stock Holding History

Inspire Advisors’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-360	Closed	-$221K	–	508
2025 Q1	$221K	Buy	+360	New	+$205K	0.03%	387

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Inspire Advisors's CHE Position: Q2 2025 in Review

Inspire Advisors sold out of Chemed (CHE) in Q2 2025, closing a stake of 360 shares — an estimated $221K sold.

Inspire Advisors first reported a position in CHE in Q1 2025 and held it in 1 quarter. The position peaked at $221K in Q1 2025. 537 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

Inspire Advisors reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
Inspire Advisors sold 360 Chemed shares in Q2 2025, an estimated $221K.
Inspire Advisors first reported a position in Chemed in Q1 2025 and held it in 1 quarter.
Inspire Advisors's Chemed position peaked at $221K in Q1 2025.
537 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on Inspire Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.